The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms
1 other identifier
interventional
24
1 country
1
Brief Summary
The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 16, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMarch 1, 2023
February 1, 2023
7 months
June 9, 2021
February 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bacterial contamination
comparison of the two ventilator systems
one month
Secondary Outcomes (1)
bacterial detection rate
one month
Study Arms (2)
SilverKnight group
EXPERIMENTALSilver Knight is an anti-microbial additive that uses silver ions to disrupt the normal enzymatic activities of bacteria
Control group
NO INTERVENTIONThe control group uses standard ventilator circuits.
Interventions
Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including: * Staphyloccus epidermis * Pseudomonas aeruginosa * Klebsiella pneumoniae * Acinetobacter calcoaceticus * Escherichia coli
Eligibility Criteria
You may qualify if:
- mechanical ventilators in Medisive CareUnit (MICU)
You may not qualify if:
- Using ventilators for less than seven days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, 24352, Taiwan
Related Publications (2)
Zilahi G, Artigas A, Martin-Loeches I. What's new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016 Dec;6(1):96. doi: 10.1186/s13613-016-0199-4. Epub 2016 Oct 6.
PMID: 27714706BACKGROUNDChao KY, Liu WL, Chen CY, Su CH, Yang SH, Huang YT. Bacterial Colonization of Silver-Additive Ventilator Circuit in Patients Receiving Mechanical Ventilation: A Randomized Controlled Trial. Clin Respir J. 2025 Mar;19(3):e70058. doi: 10.1111/crj.70058.
PMID: 40052538DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Wen-Lun Liu, MD
Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Group leader of Respiratory Therapists
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 16, 2021
Study Start
November 1, 2021
Primary Completion
June 1, 2022
Study Completion
June 30, 2022
Last Updated
March 1, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share